| Identification | Back Directory | [Name]
2H-1,4-Benzoxazine, 3,4-dihydro-7-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)- | [CAS]
1361110-64-6 | [Synonyms]
3,4-dihydro-1H-1,4-benzoxazine-7-boronic acid pinacol ester
(3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZIN-7-YL)BORONIC ACID PINACOL ESTER
2H-1,4-Benzoxazine, 3,4-dihydro-7-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-
7-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[1,4]oxazine
7-(4,4,5,5-TetraMethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine
3,4-dihydro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazine | [Molecular Formula]
C14H20BNO3 | [MDL Number]
MFCD24038761 | [MOL File]
1361110-64-6.mol | [Molecular Weight]
261.12 |
| Chemical Properties | Back Directory | [Boiling point ]
390.3±42.0 °C(Predicted) | [density ]
1.12±0.1 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2–8 °C | [pka]
3.93±0.20(Predicted) |
| Hazard Information | Back Directory | [Uses]
3,4-Dihydro-2H-1,4-benzoxazine-7-boronic acid pinacol ester is a useful intermediate for the synthesis of naphthamides which functions as VEGFR-2 kinase inhibitors for cancer treatment. |
|
|